Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David Cassie"'
Autor:
David Cassie, Janice Longstreth, Robert Hopkins, Ericka Hunter-Stitt, Bojan Drobic, Melisa Bellani
Publikováno v:
Vaccine: X, Vol 17, Iss , Pp 100431- (2024)
The recommended treatment for post-exposure prophylaxis (PEP) following known/suspected exposure to Bacillus anthracis involves immunization with anthrax vaccine adsorbed (AVA, i.e., BioThrax® vaccine) and a course of antimicrobial therapy. A drug-v
Externí odkaz:
https://doaj.org/article/c2f707da551c48a6890ee1089b609ab2
Publikováno v:
Vaccine. 41:2739-2742
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4926df73e81d7ac33739f773de64ce38
https://doi.org/10.1016/j.vaccine.2023.03.013
https://doi.org/10.1016/j.vaccine.2023.03.013
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
As part of a phase 4, randomized, double-blind, placebo-controlled trial to assess the immunogenicity and safety of PXVX0200 in children and adolescents aged 2–17 years, a subset of 73 adolescent subjects aged 12–17 years was followed for 2 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e4ba124d74c514470200b9254bbe320
http://europepmc.org/articles/PMC8103473
http://europepmc.org/articles/PMC8103473
Autor:
Paul-Andre de Lame, Douglas Haney, James M. McCarty, David Cassie, Sean Bennett, Lisa Bedell, Michael Lock
Publikováno v:
Expert review of vaccines. 21(1)
INTRODUCTION Cholera remains endemic in >50 countries, putting millions at risk, especially young children for whom killed vaccines offer limited protection. An oral, live attenuated vaccine - CVD 103-HgR (Vaxchora vaccine) - was licensed by the US F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061bf745a245cb23f08b9b07c1c973d2
https://pubmed.ncbi.nlm.nih.gov/34775892
https://pubmed.ncbi.nlm.nih.gov/34775892
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
In a phase 4, randomized, placebo-controlled, double-blind, multicenter study, to assess the safety and immunogenicity of live, attenuated cholera vaccine PXVX0200 in children aged 2–5 years in the United States, 172 volunteers were randomized 6:1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8f2e5fa77454101695224302e02970
https://pubmed.ncbi.nlm.nih.gov/33319739
https://pubmed.ncbi.nlm.nih.gov/33319739